High-dose Vitamin B1 for neurodegeneration, chronic disease, and mitochondrial restoration — all 4 forms, dosing tiers, paradoxical reaction warning, and required cofactors.
Standard thiamine RDA (1.1–1.2mg/day) prevents classic deficiency. But pharmacological mega-dosing operates through an entirely different mechanism.
Chronic toxicity, oxidative stress, and inflammation can inactivate thiamine-dependent enzymes at the cellular level — producing a state called "functional thiamine deficiency" even when blood levels appear normal. Normal dietary levels simply cannot overcome this enzymatic blockade. Pharmacological concentrations are required to saturate and restore these deranged metabolic pathways. This theory, developed by Dr. Derrick Lonsdale and further popularized by Elliot Overton (EO Nutrition), explains why high-dose B1 shows broad benefits across seemingly unrelated conditions.
Thiamine is a critical cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase — enzymes at the core of ATP production. Dysfunction → chronic fatigue, brain fog, metabolic collapse.
Thiamine deficiency produces selective damage to high-metabolic brain regions. Mega-dosing restores acetylcholine synthesis, reduces neuroinflammation, and supports myelin integrity.
Benfotiamine specifically activates transketolase, diverting glucose away from AGE-forming pathways. Directly relevant to diabetic complications, vascular aging, and neurodegeneration.
The autonomic nervous system is highly thiamine-dependent. Mega-dosing is used for dysautonomia, POTS, and vagal tone dysregulation — conditions often missed as "functional" issues.
High-dose thiamine modulates gene expression related to energy metabolism, inflammatory cytokines, and oxidative stress — effects not achievable at nutritional doses.
Thiamine is water-soluble (forms HCl, benfotiamine, TTFD). Clinical trials report no serious adverse events even at multi-gram doses. Safety profile is one of the best among any B vitamin.
Each form has distinct bioavailability, tissue distribution, and clinical applications. Choose based on your target condition.
| Form | Solubility | Bioavailability | BBB Crossing | Best For | Typical Dose |
|---|---|---|---|---|---|
| Thiamine HCl | Water-soluble | Baseline (1×) | Limited | Baseline / clinical trials, IV protocols | 100–500mg/day |
|
Benfotiamine 5–11× HCl |
Fat-soluble (S-acyl) | ~5–11× HCl | Moderate | Neuropathy, AGE inhibition, Alzheimer's, peripheral nerves | 150–600mg/day |
|
TTFD Best CNS |
Fat-soluble (disulfide) | Very high | Excellent ✅ | Brain, autonomic NS, neurodegeneration, fatigue syndromes | 25–100mg/day |
|
Sulbutiamine Nootropic |
Fat-soluble (synthetic) | High (lipophilic) | Good ✅ | Cognitive enhancement, mood, memory, fatigue (psychogenic) | 200–600mg/day |
| Dibenzoylthiamine (DBT) | Fat-soluble | Very high | Moderate | Emerging — neuroprotection, strong antioxidant profile (research stage) | TBD |
Advanced protocols often combine TTFD (for CNS/brain penetration) with benfotiamine (for peripheral nerve protection and AGE inhibition). Start with benfotiamine alone to assess tolerance, then introduce TTFD at low dose (25mg) before titrating up. This stacking approach provides complementary tissue coverage.
Relative performance across the key metrics that determine clinical efficacy for neurological applications.
The Overton/Lonsdale framework for escalating thiamine dosing — always with cofactors in place first. Individual variation is enormous; titration is mandatory.
Establish cofactor base before starting thiamine. This phase prevents paradoxical reactions and ensures enzymatic conversion is supported.
Introduce thiamine at lowest effective dose. Monitor for paradoxical reaction (fatigue, anxiety, tachycardia, insomnia). If symptoms worsen, hold and ensure cofactors are adequate.
Gradually increase dose every 1–2 weeks while monitoring symptoms. Clinical improvement often begins at 300–500mg benfotiamine or 50–100mg TTFD. May add Thiamine HCl for higher total thiamine load.
Advanced protocols used for serious neurological conditions (Parkinson's, Alzheimer's). Typically supervised. Parkinson's trials used IV or oral thiamine 1–4g/day. Sustain cofactors throughout.
The most important thing to understand about thiamine mega-dosing — and the most common reason people quit prematurely.
When thiamine begins to restore cellular energy metabolism, some individuals experience a temporary worsening of symptoms. This can manifest as increased fatigue, brain fog, anxiety, heart palpitations, insomnia, or general malaise. This is NOT an allergic reaction or sign of harm — it is a metabolic adjustment as cells ramp up ATP production after prolonged suppression. The reaction is more common with TTFD than benfotiamine due to faster CNS penetration.
Restoring oxidative energy metabolism suddenly increases metabolic demand for cofactors (especially magnesium). A temporary "nutritional debt" is called in. Additionally, rapid restoration of autonomic nerve function can trigger transient dysautonomia symptoms.
If reaction occurs: Hold dose for 1 week. Increase magnesium to 300–400mg/day. Ensure complete B-complex coverage. Resume at 50% of last dose. Titrate more slowly. Most reactions resolve within 1–3 weeks. Do NOT permanently stop — slow down instead.
Overton's protocol specifically warns against starting at high doses. Beginning at 25mg TTFD or 100mg benfotiamine — rather than therapeutic doses immediately — dramatically reduces paradoxical reaction severity. Most people who experience severe paradoxical reactions jumped straight to 100mg+ TTFD or 500mg+ benfotiamine without cofactor priming.
Thiamine cannot be activated or utilized without adequate cofactors. These are not optional additions — they are prerequisites.
Published peer-reviewed studies on high-dose thiamine in neurological conditions.
Sample maintenance protocol (Phase 3+) for cognitive and neurological support. Adjust doses based on individual response and form selection.
Benfotiamine 600mg/day: ~$25–35/mo | TTFD 50mg/day (Thiamax): ~$35–50/mo | Magnesium glycinate: ~$15/mo | B-Complex: ~$10/mo | ALA 200mg: ~$12/mo | Total: approximately $95–120/month for the full maintenance stack.
Everything you need for a complete thiamine mega-dose protocol
Affiliate links help support MeetPeptide at no extra cost to you.
Deep dives into each thiamine form and the full neuroprotection stack
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.